1. Israel Stocks

  2. •

    Healthcare

  3. •

    Medical - Devices
InMode Ltd.

InMode Ltd.

INMD
InMode Ltd.US flagNASDAQ Global Select
15.11
USD
-0.09
- -
868.25MMarket Cap
InMode Ltd.
INMD
(NASDAQ Global Select)

Recent

price

15.11

P/E

ratio

- -

div

yld

- -

ROIC.AI

2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
0.84
1.57
2.67
2.86
4.39
5.51
5.89
4.98
5.73
5.92
Revenue per Share
0.14
0.35
1.05
1.04
2.03
1.96
2.37
2.29
1.45
1.38
Basic EPS, GAAP
0.23
0.57
1.05
1.09
2.14
2.18
2.11
1.66
1.3
1.35
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
0.17
0.52
1.61
2.35
4.1
6.01
8.3
11.03
14.99
- -
Book Value per Share
0.3
0.7
3.08
3.54
5.11
6.72
9.43
8.87
10.57
10.44
Tangible Book Value per Share
64
64
58
72
81
82
84
79
65
63
Basic Weighted Avg Shares
53
100
156
206
358
454
492
395
370
375
Sales/Revenue/Turnover
16.74
31.44
38.13
35.34
46.84
43.55
39.76
28.5
23.05
21.31
Operating Margin (%)
- -
- -
- -
- -
1
1
1
1
1
1
Depreciation Expense
9
22
61
75
165
162
198
181
94
87
Net Income, GAAP
10
5.33
1.42
1.45
1.74
19.83
8.91
- -
14.95
14.69
Effective Tax Rate (%)
16.5
22.33
39.11
36.4
46.14
35.56
40.22
45.91
25.33
23.27
Profit Margin (%)
24
48
181
255
418
547
781
645
628
603
Working Capital
- -
- -
1
- -
3
4
7
5
5
5
LT Debt
19
45
180
255
416
555
787
704
683
661
Total Equity
- -
91.05
52.17
32.84
48.6
31.77
25.93
- -
10.37
10.55
Return on Invested Capital (%)
- -
98.75
91.94
55.47
64.56
38.48
32.89
- -
10.09
1,674.03
Return on Capital (%)
- -
101.9
96.22
56.99
65.54
38.92
33.28
23.11
10.18
- -
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
- -
3
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
6
5
5
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
63
63
57
Market Capitalization
995
950
866

Working Capital

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
666
699
681
Cash, Cash Equivalents & STI
532
555
537
Accounts Receivable, Net
38
44
41
Inventories
71
74
71
Total Current Liabilities
68
71
77
Payables & Accruals
17
20
17
ST Debt
- -
3
- -
Deferred Revenue
15
12
16

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
24.92%
-2.93%
Free Cash Flow
- -
12.19%
-36.15%
Net Income, GAAP
- -
16.73%
-48.24%
Sales/Revenue/Turnover
- -
16.59%
-6.16%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
80
86
130
98
395
2025
78
96
93
104
370
2026
82
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.28
0.28
0.66
1.15
2.29
2025
0.26
0.42
0.35
0.43
1.45
2026
0.18
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Similar Companies
Opto Circuits (India) Ltd. (OPTOCIRCUI.NS)
Telesis Bio, Inc. (TBIO)
Baird Medical Investment Holdings Limited (BDMD)
Aziyo Biologics, Inc. (AZYO)
Abbott Laboratories (ABT.SW)
4DMedical Limited (4DX.AX)
Business
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical devices based on proprietary radiofrequency (RF) technology. Its core product portfolio includes energy-based platforms and devices for plastic surgery, dermatology, gynecology, otolaryngology, and ophthalmology, with flagship offerings such as Morpheus8 fractional radiofrequency microneedling, Fractora, Forma RF, Lumecca IPL technology, and the recently introduced IgniteRF workstation. The company targets global markets with operations spanning North America, Europe, Asia, and Israel, where it is headquartered along with Lake Forest, California. Founded in 2008, InMode has positioned itself as a leader in innovative medical aesthetic solutions. Recent major developments include InMode's acquisition of all intellectual property assets of Viveve Medical Inc., strengthening its position in the women's health and wellness market, particularly for treatments of female stress urinary incontinence and other female wellness applications. In 2024 and 2025, the company launched next-generation products such as OPTIMAS Max and IgniteRF, which provide improved treatment efficiency and energy delivery. It also introduced a CO2 laser platform to support bundled aesthetic procedures. Additionally, InMode formed a strategic partnership with DermaFocus to incorporate Purasomes regenerative skincare products into its portfolio, enhancing outcomes for energy-based treatments. The company continues to expand its sales force globally and strengthen its international presence through subsidiary establishments and ongoing investments in research and development. InMode Ltd. remains focused on leveraging its patented RF technologies to offer innovative, minimally invasive treatment solutions across various medical aesthetic fields, supported by continuous product innovation, IP acquisitions, and strategic alliances to enhance and extend its market reach and product offerings worldwide.

Company News

APIChatGPT

  • businesswire.com

    Steel Partners Holdings L.P. Issues Letter to InMode Ltd.

  • prnewswire.com

    InMode to Report Second Quarter 2026 Financial Results on August 5, 2026, Expects Q2 Revenue Between $95.2M-$95.4M, Reiterates FY 2026 Revenue Guidance Between $365M-$375M

  • prnewswire.com

    InMode Confirms Receipt of Unsolicited Proposal

  • businesswire.com

    Steel Partners Offers to Acquire InMode for $16.75 Per Share in Cash

  • businesswire.com

    Securities Fraud Investigation Into InMode Ltd. (INMD) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

  • gurufocus.com

    InMode Ltd. (INMD) Shareholders Who Lost Money -- Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

  • businesswire.com

    InMode Ltd. (INMD) Shareholders Who Lost Money – Contact Law Offices of Howard G.

  • businesswire.com

    Securities Fraud Investigation Into InMode Ltd. (INMD) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R.

  • prnewswire.com

    DOMA PERPETUAL CAPITAL MANAGEMENT STRONGLY OPPOSES INMODE BUYOUT AS PROPOSED; PLANS TO VOTE AGAINST DEAL

  • prnewswire.com

    InMode Confirms Receipt of Unsolicited Proposal

  • seekingalpha.com

    InMode: My Pick For A Major Turnaround In 2026 And 2027

  • prnewswire.com

    InMode Appoints Dr. Shlomo Nass as Chairman of the Board and Moshik Itzkovich as Chief Financial Officer

  • prnewswire.com

    InMode to Present at Upcoming Investor Conferences and Events

  • seekingalpha.com

    InMode Ltd. (INMD) Q1 2026 Earnings Call Transcript

  • prnewswire.com

    InMode Reports First Quarter 2026 Financial Results: Quarterly GAAP Revenue of $82 Million, Represents 5% Year-Over-Year Increase

  • prnewswire.com

    InMode to Report First Quarter 2026 Financial Results and Hold Conference Call on May 6, 2026, Expects Q1 Revenue Between $81.5M-$81.7M, Reiterates FY 2026 Revenue Guidance Between $365M-$375M

  • defenseworld.net

    InMode Ltd. (NASDAQ:INMD) Receives Consensus Rating of “Hold” from Analysts

  • prnewswire.com

    InMode to Present at the 25th Annual Needham Virtual Healthcare Conference

  • defenseworld.net

    InMode Ltd. (NASDAQ:INMD) Receives Average Recommendation of “Hold” from Analysts

  • defenseworld.net

    InMode (NASDAQ:INMD) Shares Gap Up – What’s Next?